List of Excipients in API lidocaine and tetracaine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lidocaine and tetracaine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Galen US Incorporated | SYNERA | lidocaine and tetracaine | 10885-002 | METHYLPARABEN | 1969-12-31 |
| Galen US Incorporated | SYNERA | lidocaine and tetracaine | 10885-002 | POLYVINYL ALCOHOL | 1969-12-31 |
| Galen US Incorporated | SYNERA | lidocaine and tetracaine | 10885-002 | PROPYLPARABEN | 1969-12-31 |
| Galen US Incorporated | SYNERA | lidocaine and tetracaine | 10885-002 | SORBITAN MONOPALMITATE | 1969-12-31 |
| Galen US Incorporated | SYNERA | lidocaine and tetracaine | 10885-002 | WATER | 1969-12-31 |
| Taro Pharmaceuticals USA Inc | PLIAGLIS | lidocaine and tetracaine | 51672-5305 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2031-01-14 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for lidocaine and tetracaine
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
lidocaine and tetracaine drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
lidocaine and tetracaine drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Galen US Incorporated | lidocaine and tetracaine | 10885-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
lidocaine and tetracaine drug variants containing METHYLPARABEN
lidocaine and tetracaine drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
lidocaine and tetracaine drug variants containing PETROLATUM
lidocaine and tetracaine drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Galen US Incorporated | lidocaine and tetracaine | 10885-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
lidocaine and tetracaine drug variants containing POLYVINYL ALCOHOL
lidocaine and tetracaine drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
lidocaine and tetracaine drug variants containing PROPYLPARABEN
lidocaine and tetracaine drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOPALMITATE
lidocaine and tetracaine drug variants containing SORBITAN MONOPALMITATE
lidocaine and tetracaine drug variants not containing SORBITAN MONOPALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
lidocaine and tetracaine drug variants containing WATER
lidocaine and tetracaine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
